Pulse Biosciences (PLSE) Short Interest Ratio & Short Volume $15.56 -0.29 (-1.83%) Closing price 04:00 PM EasternExtended Trading$16.25 +0.69 (+4.41%) As of 05:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Pulse Biosciences Short Interest DataPulse Biosciences (PLSE) has a short interest of 2.45 million shares, representing 19.44% of the float (the number of shares available for trading by the public). This marks a 0.41% increase in short interest from the previous month. The short interest ratio (days to cover) is 14.7, indicating that it would take 14.7 days of the average trading volume of 171,653 shares to cover all short positions.Current Short Interest2,450,000 sharesPrevious Short Interest2,440,000 sharesChange Vs. Previous Month+0.41%Dollar Volume Sold Short$36.80 millionShort Interest Ratio14.7 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares67,280,000 sharesFloat Size12,600,000 sharesShort Percent of Float19.44%Today's Trading Volume156,750 sharesAverage Trading Volume171,653 sharesToday's Volume Vs. Average91% Short Selling Pulse Biosciences? Sign up to receive the latest short interest report for Pulse Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPLSE Short Interest Over TimePLSE Days to Cover Over TimePLSE Percentage of Float Shorted Over Time Pulse Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20252,450,000 shares $36.80 million +0.4%19.4%14.7 $15.02 7/15/20252,440,000 shares $37.14 million -2.4%19.4%14.2 $15.22 6/30/20252,500,000 shares $37.73 million +2.0%19.8%14.3 $15.09 6/15/20252,450,000 shares $38.64 million +2.1%19.4%12.9 $15.77 5/31/20252,400,000 shares $41.90 million -2.4%19.1%13 $17.46 5/15/20252,460,000 shares $40.57 million +3.4%19.6%13.3 $16.49 4/30/20252,380,000 shares $40.51 million +1.3%19.0%12.8 $17.02 4/15/20252,350,000 shares $40.02 million -4.5%18.7%12.6 $17.03 3/31/20252,460,000 shares $39.58 million +6.0%19.6%13.6 $16.09 3/15/20252,320,000 shares $39.23 million +2.7%20.2%14.6 $16.91 Get the Latest News and Ratings for PLSE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter. 2/28/20252,260,000 shares $41.38 million +2.7%19.7%14.1 $18.31 2/15/20252,200,000 shares $46.18 million +3.8%19.2%13.8 $20.99 1/31/20252,120,000 shares $44.37 million -0.5%18.4%12.1 $20.93 1/15/20252,130,000 shares $37.89 million +1.4%18.4%12.7 $17.79 12/31/20242,100,000 shares $36.56 million -3.2%18.2%12.8 $17.41 12/15/20242,170,000 shares $38.30 million +2.4%18.8%13.3 $17.65 11/30/20242,120,000 shares $45.37 million +1.9%12.4%12.9 $21.40 11/15/20242,080,000 shares $34.61 million -18.1%12.2%12.2 $16.64 10/31/20242,540,000 shares $44.27 million -7.6%14.9%15.9 $17.43 10/15/20242,750,000 shares $45.07 million -0.7%16.2%17.2 $16.39 9/30/20242,770,000 shares $48.59 million +0.7%16.3%14.8 $17.54 9/15/20242,750,000 shares $50.90 million -1.8%16.1%11.8 $18.51 8/31/20242,800,000 shares $52.19 million -4.8%16.5%12.2 $18.64 8/15/20242,940,000 shares $56.12 million +1.0%17.3%11.3 $19.09 7/31/20242,910,000 shares $43.53 million +3.9%23.9%10.8 $14.96 7/15/20242,800,000 shares $54.63 million +12.0%23.0%10.5 $19.51 6/30/20242,500,000 shares $27.98 million +2.9%15.3%9.9 $11.19 6/15/20242,430,000 shares $29.23 million -14.4%14.9%11 $12.03 5/31/20242,840,000 shares $32.80 million -3.1%17.4%13.2 $11.55 5/15/20242,930,000 shares $21.27 million +3.9%17.9%15.8 $7.26 4/30/20242,820,000 shares $20.78 million -3.1%17.4%16.9 $7.37 4/15/20242,910,000 shares $22.76 million +10.7%18.0%17 $7.82 3/31/20242,630,000 shares $22.91 million +5.2%16.2%14.6 $8.71 3/15/20242,500,000 shares $25.78 million -2.7%15.5%13 $10.31 2/29/20242,570,000 shares $25.39 million -1.2%15.9%10.3 $9.88 2/15/20242,600,000 shares $23.92 million -1.1%16.1%9.1 $9.20 1/31/20242,630,000 shares $23.35 million +6.5%16.3%9 $8.88 1/15/20242,470,000 shares $19.83 million +5.1%15.3%8.5 $8.03 12/31/20232,350,000 shares $28.76 million -8.2%14.5%8.7 $12.24 12/15/20232,560,000 shares $25.19 million +7.1%N/A10.2 $9.84This is my Christian duty (Ad)“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.Watch Jim Rickards reveal the Old Testament Wealth Code 11/30/20232,390,000 shares $21.58 million +2.6%N/A12.2 $9.03 11/15/20232,330,000 shares $14.87 million +8.4%N/A12.8 $6.38 10/31/20232,150,000 shares $9.72 million +3.9%N/A11.5 $4.52 10/15/20232,070,000 shares $8.40 million -2.8%N/A11.2 $4.06 9/30/20232,130,000 shares $8.58 million +4.9%N/A11.6 $4.03 9/15/20232,030,000 shares $9.50 million +8.0%N/A11.5 $4.68 8/31/20231,880,000 shares $8.85 million +9.9%N/A9.2 $4.71 8/15/20231,710,000 shares $13.54 million +0.6%N/A10.8 $7.92 7/31/20231,700,000 shares $13.43 million -5.0%N/A12.3 $7.90 7/15/20231,790,000 shares $12.53 million -4.3%N/A12.7 $7.00 6/30/20231,870,000 shares $13.45 million +17.6%N/A12.3 $7.19 6/15/20231,590,000 shares $10.35 million +3.3%N/A10 $6.51 5/31/20231,540,000 shares $9.55 million -8.3%25.8%13.6 $6.20 5/15/20231,680,000 shares $13.46 million -6.2%28.1%16.3 $8.01 4/30/20231,790,000 shares $11.53 million -5.3%11.4%20.4 $6.44 4/15/20231,890,000 shares $10.92 million -4.1%12.0%27 $5.78 3/31/20231,970,000 shares $6.62 million -5.7%12.5%30.2 $3.36 3/15/20232,090,000 shares $6.60 million +4.5%13.4%38 $3.16 2/28/20232,000,000 shares $5.46 million -5.7%12.8%26.5 $2.73 2/15/20232,120,000 shares $6.21 million -3.2%13.6%26.9 $2.93 1/31/20232,190,000 shares $6.85 million -1.8%14.0%26.2 $3.13 1/15/20232,230,000 shares $8.65 million +4.2%14.3%25.5 $3.88 12/30/20222,140,000 shares $5.93 million -5.3%13.7%23.8 $2.77 12/15/20222,260,000 shares $5.70 million -6.6%14.5%10 $2.52 11/30/20222,420,000 shares $4.84 million -1.2%15.6%10.5 $2.00 11/15/20222,450,000 shares $5.07 million +7.9%15.8%11.3 $2.07 10/31/20222,270,000 shares $4.79 million +1.3%14.7%10.1 $2.11 10/15/20222,240,000 shares $5.06 million +9.8%14.5%9.8 $2.26 9/30/20222,040,000 shares $4.69 million +6.3%13.2%8.9 $2.30 9/15/20221,920,000 shares $2.86 million +1.1%12.4%10.4 $1.49 8/31/20221,900,000 shares $2.41 million +2.7%12.3%15.8 $1.27 8/15/20221,850,000 shares $3.27 million +1.1%11.9%14.1 $1.77 7/31/20221,830,000 shares $2.85 million -3.7%11.8%11.6 $1.56 7/15/20221,900,000 shares $3.80 million No Change13.3%10.1 $2.00 6/30/20221,900,000 shares $2.91 million -21.2%21.8%7.9 $1.53 6/15/20222,410,000 shares $4.94 million -15.4%34.5%9.5 $2.05 5/31/20222,850,000 shares $6.36 million -0.7%22.0%12.1 $2.23 5/15/20222,870,000 shares $4.88 million +2.9%22.2%11.4 $1.70 4/30/20222,790,000 shares $6.98 million +12.5%21.8%10.9 $2.50 4/15/20222,480,000 shares $8.61 million -4.3%19.3%9.7 $3.47 3/31/20222,590,000 shares $12.59 million +2.0%20.3%13.6 $4.86 3/15/20222,540,000 shares $11.84 million +7.2%19.9%15.4 $4.66 2/28/20222,370,000 shares $12.04 million +13.4%18.6%15.5 $5.08 2/15/20222,090,000 shares $13.73 million +13.0%16.4%15.2 $6.57 1/31/20221,850,000 shares $22.50 million +7.6%14.5%17.2 $12.16 1/15/20221,720,000 shares $21.38 million +4.9%13.5%24.4 $12.43 12/31/20211,640,000 shares $24.29 million +4.5%12.9%30.3 $14.81 12/15/20211,570,000 shares $26.71 million +6.1%12.3%31.6 $17.01 11/30/20211,480,000 shares $30.04 million +1.4%11.6%30.2 $20.30 11/15/20211,460,000 shares $31.65 million No Change11.5%31.1 $21.68This is my Christian duty (Ad)“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.Watch Jim Rickards reveal the Old Testament Wealth Code 10/29/20211,460,000 shares $30.79 million +1.4%11.5%28.1 $21.09 10/15/20211,440,000 shares $31.18 million -2.0%11.3%25.6 $21.65 9/30/20211,470,000 shares $31.75 million -6.4%11.5%23.3 $21.60 9/15/20211,570,000 shares $32.26 million -1.9%12.3%14.2 $20.55 8/31/20211,600,000 shares $41.44 million +0.6%12.6%15 $25.90 8/13/20211,590,000 shares $35.66 million +3.9%14.8%15.5 $22.43 7/30/20211,530,000 shares $31.37 million +7.0%16.0%14.4 $20.50 7/15/20211,430,000 shares $25.93 million +7.5%14.9%13.6 $18.13 6/30/20211,330,000 shares $21.81 million -5.0%13.9%12.6 $16.40 6/15/20211,400,000 shares $24.15 million +3.7%11.1%20.8 $17.25 5/28/20211,350,000 shares $24.35 million -2.9%10.7%17.2 $18.04 5/14/20211,390,000 shares $23.84 million +12.1%11.0%15.2 $17.15 4/30/20211,240,000 shares $25.11 million +1.6%9.9%11.2 $20.25 4/15/20211,220,000 shares $26.24 million -6.2%9.8%9.3 $21.51 3/31/20211,300,000 shares $29.51 million +0.8%10.3%8.9 $22.70 3/15/20211,290,000 shares $39.82 million +6.6%10.2%8.3 $30.87 2/26/20211,210,000 shares $35.08 million +8.0%9.6%8 $28.99 2/12/20211,120,000 shares $40.36 million -10.4%9.5%7.7 $36.04 1/29/20211,250,000 shares $43.04 million -22.4%9.9%9.3 $34.43 1/15/20211,610,000 shares $40.02 million -16.6%12.7%14.1 $24.86 12/31/20201,930,000 shares $47.29 million -9.8%15.2%20.9 $24.50 12/15/20202,140,000 shares $40.23 million -7.8%16.4%22.2 $18.80 11/30/20202,320,000 shares $34.10 million -0.4%17.8%24 $14.70 11/15/20202,330,000 shares $34.62 million No Change18.0%24.2 $14.86 10/30/20202,330,000 shares $28.10 million +0.9%18.0%24.8 $12.06 10/15/20202,310,000 shares $35.14 million -2.1%17.9%25.2 $15.21 9/30/20202,360,000 shares $27.82 million -2.1%18.3%25.4 $11.79 9/15/20202,410,000 shares $28.12 million -0.8%18.7%29.4 $11.67 8/31/20202,430,000 shares $24.03 million -5.5%18.8%26.9 $9.89 PLSE Short Interest - Frequently Asked Questions What is Pulse Biosciences' current short interest? Short interest is the volume of Pulse Biosciences shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 2,450,000 shares of PLSE short. 19.44% of Pulse Biosciences' shares are currently sold short. Learn More on Pulse Biosciences' current short interest. What is a good short interest ratio for Pulse Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PLSE shares currently have a short interest ratio of 15.0. Learn More on Pulse Biosciences's short interest ratio. What is a good short interest percentage for Pulse Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 19.44% of Pulse Biosciences' floating shares are currently sold short. Is Pulse Biosciences' short interest increasing or decreasing? Pulse Biosciences saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 2,450,000 shares, an increase of 0.4% from the previous total of 2,440,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Pulse Biosciences' float size? Pulse Biosciences currently has issued a total of 67,280,000 shares. Some of Pulse Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Pulse Biosciences currently has a public float of 12,600,000 shares. How does Pulse Biosciences' short interest compare to its competitors? 19.44% of Pulse Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Pulse Biosciences: TransMedics Group, Inc. (24.19%), Soleno Therapeutics, Inc. (13.56%), Envista Holdings Corporation (5.69%), LivaNova PLC (4.19%), Warby Parker Inc. (9.29%), Inspire Medical Systems, Inc. (8.85%), Liquidia Technologies, Inc. (33.60%), PROCEPT BioRobotics Corporation (13.46%), LeMaitre Vascular, Inc. (6.49%), Artivion, Inc. (3.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Pulse Biosciences stock? Short selling PLSE is an investing strategy that aims to generate trading profit from Pulse Biosciences as its price is falling. PLSE shares are trading down $0.29 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pulse Biosciences? A short squeeze for Pulse Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PLSE, which in turn drives the price of the stock up even further. How often is Pulse Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PLSE, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies TMDX Short Interest SLNO Short Interest NVST Short Interest LIVN Short Interest WRBY Short Interest INSP Short Interest LQDA Short Interest PRCT Short Interest LMAT Short Interest AORT Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PLSE) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access